A research posted in JAMA Community Open emphasizes the discrepancy involving what it fees to make copyright along with the retail selling prices sufferers experience. Despite the very low production expenditures, Novo Nordisk has not publicly disclosed precise figures for copyright or its other merchandise, Wegovy.In Oct 2024, Novo Nordisk reveale